English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 28, 2026

THC and CBD combination rapidly reduces agitation in advanced dementia, trial finds
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Apnimed launches IPO to fund potential sleep apnea drug approval and rollout
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Experts caution against extreme health-maxxing trends promoted on social media platforms
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Study finds mobile addiction services expand care to hard-to-reach populations in Massachusetts
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Experts warn of intellectual property risks as pharma companies pursue deals in China
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Robotic knee replacement enables Ohio State physician to return to patient care
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Altimmune’s GLP-1/GIP drug reduces heavy drinking in Phase 2 alcohol use disorder trial
+ Pharmaceuticals
Patient Daily | Jul 28, 2026

Researchers identify key barrier preventing self repair of heart cells

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes